Zijie Gu - Search Results

Year	Number of Results
1997	1
2002	1
2003	1
2007	1
2009	1
2010	1
2012	1
2013	1
2014	1
2015	1
2017	2
2018	2
2020	2
2022	1
2023	2
2024	0

1

Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics.

Zhang W, Wang H, Feng N, Li Y, Gu J, Wang Z. Zhang W, et al. Among authors: gu j. Antib Ther. 2022 Nov 11;6(1):13-29. doi: 10.1093/abt/tbac029. eCollection 2023 Jan. Antib Ther. 2022. PMID: 36683767 Free PMC article. Review.

2

Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity.

Liu H, Su H, Wang F, Dang Y, Ren Y, Yin S, Lu H, Zhang H, Wu J, Xu Z, Zheng M, Gao J, Cao Y, Xu J, Chen L, Wu X, Ma M, Xu L, Wang F, Chen J, Su C, Wu C, Xie H, Gu J, Xi JJ, Ge B, Fei Y, Chen C. Liu H, et al. Among authors: gu j. Cell Rep. 2023 Mar 28;42(3):112275. doi: 10.1016/j.celrep.2023.112275. Epub 2023 Mar 20. Cell Rep. 2023. PMID: 36943864 Free article.

3

Biology drives the discovery of bispecific antibodies as innovative therapeutics.

Nie S, Wang Z, Moscoso-Castro M, D'Souza P, Lei C, Xu J, Gu J. Nie S, et al. Among authors: gu j. Antib Ther. 2020 Feb 17;3(1):18-62. doi: 10.1093/abt/tbaa003. eCollection 2020 Jan. Antib Ther. 2020. PMID: 33928225 Free PMC article. Review.

4

CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40.

Wang R, Graham S, Sun N, McCarthy D, Peng R, Erickson J, Oconnor L, Zhu X, Wurbel M, Dunstan R, Westmoreland S, Chung N, Ghayur T, Gu J. Wang R, et al. Among authors: gu j. PLoS One. 2020 Mar 10;15(3):e0228221. doi: 10.1371/journal.pone.0228221. eCollection 2020. PLoS One. 2020. PMID: 32155151 Free PMC article.

5

Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig.

Bardwell PD, Staron MM, Liu J, Tao Q, Scesney S, Bukofzer G, Rodriguez LE, Choi CH, Wang J, Chang Q, Dong F, Donawho C, Wang J, Grinnell CM, Tarcsa E, Hutchins C, Ghayur T, Gu J. Bardwell PD, et al. Among authors: gu j. Protein Cell. 2018 Jan;9(1):121-129. doi: 10.1007/s13238-017-0429-z. Epub 2017 Jun 5. Protein Cell. 2018. PMID: 28585177 Free PMC article.

6

Rationale and development of multispecific antibody drugs.

Gu J, Ghayur T. Gu J, et al. Expert Rev Clin Pharmacol. 2010 Jul;3(4):491-508. doi: 10.1586/ecp.10.28. Expert Rev Clin Pharmacol. 2010. PMID: 22111679

7

Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.

Gu J, Ghayur T. Gu J, et al. Methods Enzymol. 2012;502:25-41. doi: 10.1016/B978-0-12-416039-2.00002-1. Methods Enzymol. 2012. PMID: 22208980

8

Identification of anti-ErbB2 dual variable domain immunoglobulin (DVD-Ig™) proteins with unique activities.

Gu J, Yang J, Chang Q, Lu X, Wang J, Chen M, Ghayur T, Gu J. Gu J, et al. PLoS One. 2014 May 13;9(5):e97292. doi: 10.1371/journal.pone.0097292. eCollection 2014. PLoS One. 2014. PMID: 24824849 Free PMC article.

9

Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule.

Jakob CG, Edalji R, Judge RA, DiGiammarino E, Li Y, Gu J, Ghayur T. Jakob CG, et al. Among authors: gu j. MAbs. 2013 May-Jun;5(3):358-63. doi: 10.4161/mabs.23977. Epub 2013 Apr 2. MAbs. 2013. PMID: 23549062 Free PMC article.

10

Identification of Anti-EGFR and Anti-ErbB3 Dual Variable Domains Immunoglobulin (DVD-Ig) Proteins with Unique Activities.

Gu J, Yang J, Chang Q, Liu Z, Ghayur T, Gu J. Gu J, et al. PLoS One. 2015 May 21;10(5):e0124135. doi: 10.1371/journal.pone.0124135. eCollection 2015. PLoS One. 2015. PMID: 25997020 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year